Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: COX-2 inhibitor
Total 0 results
Nothing found
Sponsors and Collaborators
The Second Affiliated and Yuying Children's Hospital of Wenzhou Medical University
Numbers Whizzy
Annick Desjardins, MD
LEAF Weight Loss Clinic
Fundación Vithas-Nisa
Fundação de Amparo a Pesquisa do Distrito Federal
eResearchTechnology
Schering SA
Inha University Hospital
Musclegen Research, Inc.
Bionou Research, S.L.
Rizky Kusuma Wardhani
Zhongda Hospital
Haseki Sultangazi Teaching and Research Hospital, University of Health Sciences
Jean-Luc Van Laethem
Washington Regional Medical Center
Start from scratch
Tarumanagara University
Dr.Ruba Musharbash
Race Oncology Ltd
View Full List
Medical Conditions
Anxiety ; Dental
Resectable Breast Carcinoma
Stiffness, Arterial
Loss of Medical Decision Making Capacity
Anemia
Preeclampsia/Toxemia
Mayer Rokitansky Kuster Hauser Syndrome
Anandamide
Osteosarcoma of Pelvis
Non-Diabetic
Obstuctive Jaundice
Perform PVP / PKP Treatment
Low-Frequency Residual Hearing
EGFR Overexpression
HoFH
Amelia of Upper Limb
Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
Damage Dna
Juxtarenal Aneurysms
Newborn Hypothermia
View Full List
Drug Interventions
HB0036
Botulin toxin
Lipoic acid
Topiramate
Filgotinib
Norepinephrine
Medium-dose ZKY001 eye drops
Fludarabine Injection
Amoxicillin, levofloxacin, ofloxacin, sulfamethoxazole/trimethoprim
Losec
Double-Blind Rituximab
Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy, distant lymph node 0.5Gy*4)
Metoclopramide 10 mg
Ranitidine (or equivalent)
0.15% azelastine hydrochloride
Liposomal doxorubicin
Methylnaltrexone bromide
Tocilizumab Injection
Cohort B: ORMD-0801
Linifanib
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Angola
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Estonia
Contract Research Organizations in Indonesia
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Mauritania
Contract Research Organizations in Mauritius
Contract Research Organizations in Montenegro
Contract Research Organizations in Paraguay
Contract Research Organizations in Senegal
Contract Research Organizations in Tanzania
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Japan
CMIC Group
ICON
InCROM
KRI, Inc. (Kansai Research Institute)
Caidya
Parexel
Asklep
eResearchTechnology, Inc (ERT)
Alcami
IQVIA
All CROs in Japan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe